Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.38 | 31.65 |
| PEG Ratio (TTM) | -2.34 | -1.17 |
| P/S Ratio (TTM) | 0.22 | 4.72 |
| P/B Ratio (TTM) | 0.97 | 6.16 |
| P/FCF Ratio (TTM) | 43.02 | 34.57 |
| Price to 5YR AVG Earnings Ratio | 58.93 | 47.14 |
| Price to 5YR AVG FCF Ratio | -46.88 | 52.94 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.19% | 8.81% |
| ROE (TTM) | 5.61% | 21.70% |
| Net Profit Margin (TTM) | 1.01% | 11.50% |
| ROIC 5YR AVG | 5.33% | 20.67% |
Growth (20%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -14.68% | -190.12% | -91.75% |
| Revenue | 0.09% | -3.78% | 0.73% |
| Net Income | -14.53% | -194.03% | -93.96% |
| Cash Flow | 71.33% | -45.82% | 38.19% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.45 | 1.73 |
| Quick Ratio (TTM) | 1.26 | 1.16 |
| D/E Ratio (TTM) | 1.97 | 0.63 |
| Interest Coverage (TTM) | 1.92 | 17.45 |
| Piotroski F-Score | 8 | 7 |
| Altman Z-Score | 2.31 | 5.37 |
| LTL to 5YR AVG FCF | -84.01 | 6.02 |
| Shares Outstanding Growth 5YR AVG | 0.07% | 0.54% |